What is China-Gel?
China-Gel LLC has established itself over three decades as a trusted provider of natural pain relief. Their core offerings, including aulief, aulief Gold, and Therapy Creme, are formulated with ancient herbs to address a range of discomforts such as arthritis, backache, and muscle and joint pain. The company serves both individual consumers seeking natural remedies and professionals within the health and wellness sector, underscoring a dual market strategy.
How much funding has China-Gel raised?
China-Gel has raised a total of $55K across 1 funding round:
Debt
$55K
Debt (2021): $55K with participation from PPP
Key Investors in China-Gel
PPP
Public-Private Partnership
What's next for China-Gel?
With significant Series B/C stage backing, China-Gel is poised for substantial growth. The recent influx of expansion capital is expected to fuel strategic initiatives, potentially including market penetration, product line enhancement, and scaling of operations. The company's long-standing reputation for efficacy and natural formulations provides a strong foundation for future development and increased market share in the competitive pain relief industry.
See full China-Gel company page
